Sciclone Pharmaceut (SCLN) 13.02 $SCLN Sciclone

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sciclone Pharmaceut (SCLN) 13.02 $SCLN

Sciclone Pharmaceuticals Has Returned 70.9% Since SmarTrend Recommendation (SCLN)
Comtex SmarTrend(R) - Fri Jun 10, 12:40PM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on November 9th, 2015 at $7.98. In approximately 7 months, Sciclone Pharmaceuticals has returned 70.93% as of today's recent price of $13.63.
SCLN: 13.02 (-0.41)

Shares of SCLN Up 74.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 03, 12:11AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on November 9th, 2015 at $7.98. In approximately 7 months, Sciclone Pharmaceuticals has returned 74.17% as of today's recent price of $13.89.
SCLN: 13.02 (-0.41)

Sciclone Pharmaceuticals Shares Up 62.9% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Thu May 26, 12:40PM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on November 9th, 2015 at $7.98. In approximately 7 months, Sciclone Pharmaceuticals has returned 62.88% as of today's recent price of $12.99.
SCLN: 13.02 (-0.41)

AWS Morning Technical Breakdown Highlights: Novo Nordisk, Biodel, Sucampo Pharma, and SciClone Pharma
ACCESSWIRE - Mon May 23, 8:16AM CDT
LONDON, UK / ACCESSWIRE / May 23, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include Novo Nordisk, Biodel, Sucampo Pharma, and SciClone Pharma.
NVO: 51.72 (-1.68), SCMP: 10.64 (-0.31), SCLN: 13.02 (-0.41), BIOD: 0.30 (-0.01)

Uptrend Call Working As Sciclone Pharmaceuticals Stock Rises 64.4% (SCLN)
Comtex SmarTrend(R) - Wed May 11, 12:42PM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on November 9th, 2015 at $7.98. In approximately 6 months, Sciclone Pharmaceuticals has returned 64.39% as of today's recent price of $13.11.
SCLN: 13.02 (-0.41)

SciClone Reports First Quarter 2016 Financial Results
PR Newswire - Tue May 10, 5:00AM CDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended March 31, 2016.
SCLN: 13.02 (-0.41)

SciClone Pharmaceuticals To Report First Quarter 2016 Financial Results On May 10, 2016
PR Newswire - Mon Apr 25, 5:00AM CDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the first quarter 2016 on Tuesday, May 10, 2016. SciClone will host a conference call and webcast to provide a business and product update at 8:30 am ET (5:30 am PT) that day. The call will be hosted by Friedhelm Blobel, Ph.D., President and CEO, and Wilson W. Cheung, Senior Vice President and CFO.
SCLN: 13.02 (-0.41)

Shares of SCLN Up 62.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 19, 12:15AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on November 9th, 2015 at $7.98. In approximately 5 months, Sciclone Pharmaceuticals has returned 62.51% as of today's recent price of $12.96.
SCLN: 13.02 (-0.41)

Sciclone Pharmaceuticals Shares Up 55.3% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Mon Apr 11, 12:38PM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on November 9th, 2015 at $7.98. In approximately 5 months, Sciclone Pharmaceuticals has returned 55.30% as of today's recent price of $12.39.
SCLN: 13.02 (-0.41)

Shares of SCLN Up 37.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Apr 01, 12:38PM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on November 9th, 2015 at $7.98. In approximately 5 months, Sciclone Pharmaceuticals has returned 37.62% as of today's recent price of $10.98.
SCLN: 13.02 (-0.41)

Look for Shares of Sciclone Pharmaceuticals to Potentially Pullback after Yesterday's 13.34% Rise
Comtex SmarTrend(R) - Thu Mar 31, 3:35PM CDT
Sciclone Pharmaceuticals (NASDAQ:SCLN) traded in a range yesterday that spanned from a low of $10.35 to a high of $10.99. Yesterday, the shares gained 13.3%, which took the trading range above the 3-day high of $9.99 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SCLN: 13.02 (-0.41)

WebMD Health Set to Join the S&P MidCap 400; SciClone Pharmaceuticals to Join S&P SmallCap 600
PR Newswire - Wed Mar 30, 5:24PM CDT
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices after the close of trading on Friday, April 1:
WBMD: 59.66 (-1.09), TMO: 148.08 (-4.06), SUNE: 0.34 (unch), SCLN: 13.02 (-0.41), MHFI: 107.92 (+1.16), AFFX: 14.01 (+0.02)

SciClone To Present At Needham Healthcare Conference On April 13, 2016
PR Newswire - Wed Mar 30, 5:00AM CDT
FOSTER CITY, Calif., March 30, 2016 /PRNewswire/-- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Wilson W. Cheung, Chief Financial Officer, will present a corporate overview and business update at the 15th Annual Needham Healthcare Conference at 8:00 am ET on Wednesday, April 13, 2016, at the Westin Grand Central Hotel in New York City.
SCLN: 13.02 (-0.41)

OxySure Therapeutics (OXYS) May Be Undervalued Compared to Others in Biotech Space
ACCESSWIRE - Mon Mar 21, 8:01AM CDT
REDONDO BEACH, CA / ACCESSWIRE / March 21, 2016 / OxySure Therapeutics Inc. (OTCQB: OXYS), developer of oxygen-from-powder technology and related medical solutions, has come a long way over the past year. Management anticipates reaching a $10 million annual run rate and achieving breakeven later this year. With 14 consecutive quarters of revenue growth, the company has a long track record of increasing shareholder value.
SRDX: 23.12 (-0.94), CFMS: 6.80 (-0.29), GKOS: 29.13 (+0.38), BEAT: 15.44 (-0.45), SCLN: 13.02 (-0.41)

SciClone Reports 2015 Financial Results
PR Newswire - Thu Mar 10, 3:05PM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter and year ended December 31, 2015.
SCLN: 13.02 (-0.41)

LifeSci Capital Initiates Coverage of SciClone
ACCESSWIRE - Tue Mar 08, 1:45PM CST
Profitable Specialty Pharmaceutical Company with Steady Revenue Growth; Report Available here: http://www.lifescicapital.com/equity-research/sciclone/
BAX: 44.48 (-1.48), PFE: 34.13 (-0.46), SCLN: 13.02 (-0.41)

27.3% Return Seen to Date on SmarTrend Sciclone Pharmaceuticals Call (SCLN)
Comtex SmarTrend(R) - Mon Mar 07, 5:13PM CST
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on November 9th, 2015 at $7.98. In approximately 4 months, Sciclone Pharmaceuticals has returned 27.27% as of today's recent price of $10.15.
SCLN: 13.02 (-0.41)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 232

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 119

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 266

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 339

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 201

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 99

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 163

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Roku Inc. Shares Surge Following Strong Fiscal Report

Updated Category News Views 247

Roku Inc. Shows Resilience in Latest Earnings Report Roku, Inc. (NASDAQ: ROKU) has made headlines recently as its stock takes a positive turn following the release of its fourth-quarter results for the fiscal year 2024. The company's performance exceeded expectations, giving investors and analysts alike a reason to take notice. Strong Earnings Beat Analysts' Predictions...

Continue Reading
Cupshe Dominates Miami Swim Week with Unique Showcase

Updated Category News Views 145

Fashion Meets Storytelling at Miami Swim Week Well, it's official: Cupshe has shown up at Miami Swim Week 2026 with an offering that's turning heads. We're not just talking about another run-of-the-mill runway show. This edition, held at Temple House in Miami Beach, brought an immersive experience dubbed 'The Arrival'. They showcased 45 looks, making a statement with...

Continue Reading
AmeriServ Financial's New Contract Strengthens Workforce Relations

Updated Category News Views 136

AmeriServ Financial's New Labor Contract: A Positive Step Forward AmeriServ Financial Inc. (NASDAQ: ASRV) has successfully forged a new four-year labor contract with the United Steelworkers (USW) Local 2635-06. This recent agreement signifies a proactive approach to employee relationships, ensuring the bank remains a vital part of the community. Details of the Agreement...

Continue Reading
AS Tallink Grupp's Passenger and Cargo Transport Insights

Updated Category News Views 230

Overview of AS Tallink Grupp's May 2025 Performance In May 2025, AS Tallink Grupp reported the transportation of 472,683 passengers, reflecting a slight decline of 2.0% from the previous year. This decrease in passenger numbers is indicative of the ongoing challenges in the transportation sector. Along with passenger counts, the number of cargo units also saw a...

Continue Reading
B2B Food and Beverages E-commerce Market Insights for Future Growth

Updated Category News Views 248

The Expanding Landscape of B2B Food and Beverages E-commerce The B2B food and beverages e-commerce market is on an impressive trajectory, projected to ascend from USD 255.63 billion in 2024 to an astounding USD 1.15 trillion by 2034. This growth is fueled by an increasing demand for online transactions, ease of accessing supplies, and the innovation of diverse food and...

Continue Reading